| Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on … AC Goldberg, PN Hopkins, PP Toth, CM Ballantyne, DJ Rader, ... Journal of clinical lipidology 5 (3), 133-140, 2011 | 1045 | 2011 |
| Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile SS Martin, MJ Blaha, MB Elshazly, PP Toth, PO Kwiterovich, ... Jama 310 (19), 2061-2068, 2013 | 940 | 2013 |
| Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association HE Bays, PP Toth, PM Kris-Etherton, N Abate, LJ Aronne, WV Brown, ... Journal of clinical lipidology 7 (4), 304-383, 2013 | 675 | 2013 |
| Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014 | 600 | 2014 |
| Statin intolerance–an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical … M Banach, M Rizzo, PP Toth, M Farnier, MH Davidson, K Al-Rasadi, ... Expert opinion on drug safety 14 (6), 935-955, 2015 | 593 | 2015 |
| Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel AFG Cicero, A Colletti, G Bajraktari, O Descamps, DM Djuric, M Ezhov, ... Nutrition reviews 75 (9), 731-767, 2017 | 555 | 2017 |
| Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications SS Martin, MJ Blaha, MB Elshazly, EA Brinton, PP Toth, JW McEvoy, ... Journal of the American College of Cardiology 62 (8), 732-739, 2013 | 481 | 2013 |
| Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia PN Hopkins, PP Toth, CM Ballantyne, DJ Rader Journal of clinical lipidology 5 (3), S9-S17, 2011 | 458 | 2011 |
| Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists MH Davidson, CM Ballantyne, TA Jacobson, VA Bittner, LT Braun, ... Journal of clinical lipidology 5 (5), 338-367, 2011 | 446 | 2011 |
| Ezetimibe therapy: mechanism of action and clinical update BAP Phan, TD Dayspring, PP Toth Vascular health and risk management, 415-427, 2012 | 406 | 2012 |
| High-density lipoproteins: a consensus statement from the National Lipid Association PP Toth, PJ Barter, RS Rosenson, WE Boden, MJ Chapman, M Cuchel, ... Journal of clinical lipidology 7 (5), 484-525, 2013 | 382 | 2013 |
| Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association PB Duell, FK Welty, M Miller, A Chait, G Hammond, Z Ahmad, DE Cohen, ... Arteriosclerosis, thrombosis, and vascular biology 42 (6), e168-e185, 2022 | 376 | 2022 |
| Prevalence of lipid abnormalities in the united states: the national health and nutrition examination survey 2003–2006 PP Tóth, D Potter, EE Ming Journal of clinical lipidology 6 (4), 325-330, 2012 | 352 | 2012 |
| Prevalence of statin intolerance: a meta-analysis I Bytyci, PE Penson, DP Mikhailidis, ND Wong, AV Hernandez, ... European heart journal 43 (34), 3213-3223, 2022 | 345 | 2022 |
| Subclinical atherosclerosis: what it is, what it means and what we can do about it PP Toth International journal of clinical practice 62 (8), 1246-1254, 2008 | 329 | 2008 |
| Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 … D Morrone, WS Weintraub, PP Toth, ME Hanson, RS Lowe, J Lin, ... Atherosclerosis 223 (2), 251-261, 2012 | 328 | 2012 |
| Inflammation and cardiovascular disease: From mechanisms to therapeutics A Alfaddagh, SS Martin, TM Leucker, ED Michos, MJ Blaha, ... American journal of preventive cardiology 4, 100130, 2020 | 297 | 2020 |
| Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease PP Toth Vascular health and risk management, 171-183, 2016 | 297 | 2016 |
| Residual macrovascular risk in 2013: what have we learned? JC Fruchart, J Davignon, MP Hermans, K Al-Rubeaan, P Amarenco, ... Cardiovascular diabetology 13, 1-17, 2014 | 247 | 2014 |
| Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials M Banach, C Serban, A Sahebkar, S Ursoniu, J Rysz, P Muntner, PP Toth, ... Mayo Clinic Proceedings 90 (1), 24-34, 2015 | 245 | 2015 |
Maciej BanachVice-Rector for Faculty of Medicine, KUL; President, International Lipid Expert Panel, Polandumed.lodz.pl의 이메일 확인됨